The transient receptor potential family of ion channels (original) (raw)

Abstract

Summary

The transient receptor potential (TRP) multigene superfamily encodes integral membrane proteins that function as ion channels. Members of this family are conserved in yeast, invertebrates and vertebrates. The TRP family is subdivided into seven subfamilies: TRPC (canonical), TRPV (vanilloid), TRPM (melastatin), TRPP (polycystin), TRPML (mucolipin), TRPA (ankyrin) and TRPN (NOMPC-like); the latter is found only in invertebrates and fish. TRP ion channels are widely expressed in many different tissues and cell types, where they are involved in diverse physiological processes, such as sensation of different stimuli or ion homeostasis. Most TRPs are non-selective cation channels, only few are highly Ca2+ selective, some are even permeable for highly hydrated Mg2+ ions. This channel family shows a variety of gating mechanisms, with modes of activation ranging from ligand binding, voltage and changes in temperature to covalent modifications of nucleophilic residues. Activated TRP channels cause depolarization of the cellular membrane, which in turn activates voltage-dependent ion channels, resulting in a change of intracellular Ca2+ concentration; they serve as gatekeeper for transcellular transport of several cations (such as Ca2+ and Mg2+), and are required for the function of intracellular organelles (such as endosomes and lysosomes). Because of their function as intracellular Ca2+ release channels, they have an important regulatory role in cellular organelles. Mutations in several TRP genes have been implicated in diverse pathological states, including neurodegenerative disorders, skeletal dysplasia, kidney disorders and pain, and ongoing research may help find new therapies for treatments of related diseases.

Gene organization and evolutionary history

Transient receptor potential (TRP) genes were first described in the fruit fly Drosophila melanogaster. Studies in its visual system identified a visually impaired mutant fly that had a transient response to steady light instead of the sustained electro-retinogram recorded in the wild type [1]. This mutant was therefore called transient receptor potential; however, it took about two decades before the trp gene was identified by Montell and Rubin in 1989 [2]. From its structural resemblance to other cation channels and detailed analysis of the permeation properties of the light-induced current in the trp mutant, the product of the trp gene was proposed to be a six-transmembrane-segment protein that functions as a Ca2+-permeable cation channel [3]. Currently, more than 100 TRP genes have been identified in various animals (Table 1). Human TRP genes are diverse in length and range between 11.4 and about 911 kb, with the number of exons varying from 11 to 39. The overall protein sequence homology between subfamily members in the same species is usually about 35%, but for clear duplication pairs (such as TRPC6 and TRPC7, TRPM4 and TRPM5, and TRPV5 and TRPV6) this may reach 50 to 80%. Regulatory elements in promoters of TRP genes have not been identified.

Table 1.

The TRP channel familya

From protein homology, members of the TRP channel family can be seen to fall into seven subfamilies [4]. The number of channels within each subfamily varies across species (Figure 1 and Table 1). The transmembrane segments tend to share the greatest homology within a particular subfamily. The TRPC subfamily ('canonical') comprises closest homologs of Drosophila trp channels. TRPVs ('vanilloid') are named after a founding member vanilloid receptor 1 (now TRPV1). The TRPM subfamily groups homologs of melastatin-1 (now TRPM1). TRPMLs and TRPPs include mucolipins and polycystins, respectively. All members of the TRPA subfamily are nociceptive channels characterized by the presence of about 14 ankyrin repeats. The TRPN subfamily is named after the 'NO-mechano-potential C' (NOMP-C) channel of Caenorhabditis elegans. So far, the only TRPN family member to be identified in vertebrates is from zebrafish [5].

Figure 1.

A phylogenetic tree of human TRP channels. Sequence homology analyses show that all TRP channels fall into seven subfamilies that comprise proteins with distinct channel properties. Because TRPC2 is a pseudogene in human and TRPNs are not present in mammals, we used mouse TRPC2 (ENSMUSP00000102562) and fish TRPN1 (ENSDARP00000093955) to show relations between all subfamilies. Protein sequences were aligned using ClustalW2 at the EMBL-EBI server. Phylogenetic distances were calculated using PAM matrix and the unrooted tree was obtained using NJplot [102]. The TRP subfamilies are represented by different colors. The scale bar represents 0.2 substitutions. Ensembl protein IDs for human protein sequences used in the analysis are as follows: TRPM1, ENSP00000380897; TRPM2, ENSP00000381023; TRPM3, ENSP00000350140; TRPM4, ENSP00000252826; TRPM5, ENSP00000387965; TRPM6, ENSP00000354006; TRPM7, ENSP00000320239; TRPM8, ENSP00000323926; TRPV1, ENSP00000174621; TRPV2, ENSP00000342222; TRPV3, ENSP00000301365; TRPV4, ENSP00000261740; TRPV5, ENSP00000265310; TRPV6, ENSP00000352358; TRPC1, ENSP00000273482; TRPC3, ENSP00000368966; TRPC4, ENSP00000369003; TRPC5, ENSP00000262839; TRPC6, ENSP00000340913; TRPC7, ENSP00000426070; TRPML1, ENSP00000264079; TRPML2, ENSP00000359640; TRPML3, ENSP00000304843; TRPP2, ENSP00000237596; TRPP3, ENSP00000325296; TRPP5, ENSP00000290431; TRPA1, ENSP00000262209.

Within the six kingdoms of life, bacteria, protozoa, chromista, plantae, fungi and animalia [6], TRP-related genes seem to be found only in fungi and animalia. Despite extensive genomic studies, no single TRP-encoding gene has been identified in land plants so far, but the genome of chlorophyte algae seems to contain several types of putative TRP-like genes [7]. In the green alga Ostreococcus tauri, at least one of the putative genes might encode a potential TRP channel involved in a Ca2+ signaling pathway. Therefore, land plants might have lost TRP channels after their divergence from the chlorophyte algae [7].

In fungi, the TRP family is represented by a single member, TrpY1 (also known as Yvc1 for yeast vacuolar conductance 1), which encodes a vacuolar membrane protein that functions as a mechano-sensor of vacuolar osmotic pressure in yeast [8-11]. The yeast TRP channel is activated in a Ca2+-dependent manner through stretching of the vacuolar membrane [12,13] as well as by indole and other aromatic compounds [8,9]. The action of aromatic ligands requires the presence of aromatic residues in the sixth transmembrane segment that might be counterparts of those found in several TRP channels of multicellular organisms [8,9]. Because TrpY1p shares only partial homology with other known TRPs, it might be considered as one of the ancient mechano- and chemosensors [14,15].

Choanoflagellates are unicellular and colonial organisms considered to be the common ancestor of animals. It has been hypothesized that these colony-forming flagellate eukaryotes developed a Ca2+ signaling system that comprises homologs of various types of animal plasma membrane Ca2+ channels, including the store-operated channel, ligand-operated channels, voltage-operated channels, second messenger-operated channels, and five out of six animal TRP channel families [16]. Thus, it is very likely that these choanoflagellate genes served as ancestors for the evolution of different TRP subfamilies in animals; further expansions within subfamilies may have mainly occurred by gene duplications (Figure 1). During evolution, most vertebrates lost the mechanosensitive TRPN channels but almost doubled the number of TRPs involved in calcium and magnesium homeostasis, thermo- and chemosensing and calcium signaling (TRPCs, TRPVs and TRPMs; Table 1).

Characteristic structural features

Owing to the shortage of accurate X-ray crystallography data describing the three-dimensional structure of an entire TRP channel, most information concerning TRP domain composition comes from in silico and structure/function relationship studies. It is thought that most TRPs function as homotetramers. The formation of heteromultimeric channels between members of the same subfamily or different subfamilies has been described in several cases (such as between the TRPCs), and this could potentially create a wide variety of channels; however, it is debatable whether or not these multimeric channels are formed [17]. A typical TRP protein contains six putative transmembrane segments (S1 to S6) with a pore-forming reentrant loop between S5 and S6 [18,19] (Figure 2). Intracellular amino and carboxyl termini are variable in length and consist of a variety of domains [18]. From cryo-electron microscopy data on TRPC3, the large intracellular domain can be seen as a 'nested box' structure: a 'wire frame' outer shell acts as a sensor for activators and modulators, and a globular inner chamber might modulate ion flow [20]. Interestingly, in a few cases the carboxy-terminal tails contain entire enzyme activities. For example, a Nudix hydrolase domain of TRPM2 functions as an ADP-ribose pyrophosphatase [21]. In TRPM6 and TRPM7 an atypical α-kinase domain is involved in regulation of channel function [22,23]. Another feature in the amino termini of many TRPs is the presence of ankyrin repeats, 33-residue motifs consisting of pairs of antiparallel α-helices connected by β-hairpin motifs. The number of repeats in the ankyrin repeat domain (ARD) can vary between different TRPs: 3 to 4 in TRPCs, 6 in TRPVs, 14 to 15 in TRPAs and about 29 in TRPNs. Functionally, ARD seems to be connected with tetramerization of the channel and interactions with ligands and protein partners [24]. Currently, the ARD of TRPV channels is the only domain out of the entire TRP superfamily for which high resolution crystallographic data have so far been obtained [25,26].

Figure 2.

Predicted structural topology of TRP channels. (a) All channels contain six transmembrane segments (S1 to S6) with a putative pore region (P) between S5 and S6. Amino and carboxyl termini are variable in length and contain different sets of domains. (b) Distribution of domains in selected human TRP channels [103]. The number and composition of domains vary between different TRP channels and are only partially preserved within members of the same subfamily. aa, amino acids; CaM, calmodulin; EF hand, helix-loop-helix Ca2+ binding motif; PH, pleckstrin homology domain; ER, endoplasmic reticulum; NUDIX domain, nucleoside diphosphate linked moiety X-type motif.

The presence of other domains and motifs that influence channel functions, such as coiled coils, calmodulin-binding sites, lipid-interaction domains, EF hands or phosphorylation sites, is highly variable and very often not preserved in all members within the same subfamily (for more details see [18]).

Localization and function

TRPs are expressed in almost every cell type in both excitable and non-excitable tissues (Table 2). TRP channels are present in all cellular membranes, with the exception of the nuclear envelope and mitochondria. Most TRP channels are localized in the plasma membrane, where they have an essential role in the influx and/or transcellular machinery that transports Ca2+, Mg2+ and trace metal ions, and they modulate the driving force for ion entry. These contributions are essential for several physiological processes, ranging from pure sensory functions (such as pheromone signaling, taste transduction, nociception and temperature sensation) and homeostatic functions (such as Ca2+ and Mg2+ reabsorption and osmoregulation) to many other motile functions, such as muscle contraction and vasomotor control.

Table 2.

Expression and function of human and mouse TRP channels

The functions of TRP channels at specific locations are often modulated by their associations with accessory proteins (such as TRPV4 and PACSIN3, a protein kinase C and casein kinase II substrate in neurons that is involved in synaptic vesicular membrane trafficking and regulation of dynamin-mediated endocytotic processes) and by formation of signaling complexes with various signaling proteins (such as TRPM4 and phospholipase C (PLC) isoforms and phosphatidylinositol kinases/phosphatases) [27,28]. Currently, the mechanisms of intracellular trafficking of TRP channels and their guidance to the plasma membrane or to intracellular locations are mostly unknown [29].

TRPs and disease

Several TRP genes are implicated in a wide range of diseases in humans [30,31]. These fall under the umbrella of the 'channelopathies', which are defined as diseases caused by impaired channel functions, resulting from either mutations in the encoding gene or an acquired mechanism, such as autoimmunity.

TRPC6

Mutations in TRPC6 are linked to the human proteinuric kidney disease called focal and segmental glomerulosclerosis (FSGS). FSGS patients show defects in the permeability barrier function in glomeruli, resulting in proteinuria and progressive kidney failure [32-34].

TRPV4

Mutations in TRPV4 are linked with inherited disorders of bone growth, including brachyolmias and skeletal dysplasias mainly characterized by short trunk, scoliosis and mild short stature [35].

TRPV4 has also been implicated in neurodegenerative disorders, such as scapuloperoneal spinal muscular atrophy (SPSMA) and Charcot-Marie-Tooth disease type 2C (CMT2C, known also as hereditary motor and sensory neuropathy type 2C) [36-39]. SPSMA is described by progressive weakness of scapular and peroneal muscle tissue, bone abnormalities and laryngeal palsy (the paralysis often being accompanied by loss of sensation). CMT2C results in progressive weakness of distal limbs, vocal cords, diaphragm, and intercostal and laryngeal muscles; impaired hearing and vision; some bone abnormalities, such as scoliosis; and bladder urgency and incontinence [36,37,39].

TRPM1

Melastatin or TRPM1 has been identified as a putative tumor suppressor in melanoma cells [40-42]. Mutations in TRPM1 are linked to autosomal-recessive congenital stationary night blindness (CSNB). CSNB is a heterogeneous group of retinal disorders characterized by nonprogressive impaired night vision and variable decreased visual acuity as a consequence of the loss of function of rod and cone ON bipolar cells in the retina [43-47].

TRPM4

Mutations resulting in Asn7Lys substitution in the amino-terminal part of the TRPM4 channel cause autosomal-dominant progressive familial heart block type 1 (PFHB1), a cardiac bundle branch disorder that affects the electrical conduction of the heart and may progress to a complete heart block. Increased TRPM4 mutant channel density in the plasma membrane, resulting from impaired endocytosis, very likely depolarizes the conduction system and causes the heart block [48].

TRPM6

The TRPM6 locus is associated with hypomagnesemia with secondary hypocalcemia (HSH/HOMG), an autosomal recessive disorder characterized by low Mg2+ and Ca2+ levels in serum, resulting from impaired intestinal Mg2+ absorption and renal Mg2+ leak [49,50]. TRPM6 has a crucial role in active transcellular Mg2+ uptake at the apical membrane of the brush-border epithelium in intestines. Magnesium overload is also prevented by TRPM6, which is tightly regulated by the intracellular Mg2+ concentration [51].

TRPA1

The nociceptive TRPA1 channel is implicated in the etiology of an autosomal dominant familial episodic pain syndrome (FEPS) that is manifested by episodes of upper body pain, triggered by fasting and physical stress. FEPS patients show an enhanced cutaneous flare response with secondary hyperalgesia to punctuate stimuli in the presence of TRPA1 agonists [52].

TRPML1

Mucolipidosis type IV (MLIV) is caused by mutations in TRPML1. MLIV, an autosomal-recessive neurodegenerative lysosomal storage disorder is linked with psychomotor retardation, ophthalmologic abnormalities, failure of corpus callosum development, blood iron deficiency and achlorhydria [53]. TRPML1 is a calcium and iron permeable intracellular channel in lysosomes and, therefore, possible pathological mechanisms might include block of the endocytotic pathway at the late endosome-lysosome level, a defect in autophagy of endocytosed materials and impaired iron transport [54,55].

TRPP2

Polycystic kidney disease (PKD), the most common inherited form of kidney failure, is associated with a mutation in TRPP2 (known also as polycystin 2). PKD is characterized by the development of large epithelial-lined cysts that are filled with fluid and can occupy much of the mass of the abnormally enlarged kidneys, thereby compressing and destroying normal renal tissue and impairing kidney function [56].

Mechanism

The activity of TRP channels is regulated by a variety of mechanisms. In general, these processes require the whole complement of post-transcriptional modifications, including G-protein-coupled receptor-related mechanisms, (de)phosphorylation and ubiquitination. Some more general mechanisms of TRP channel gating and their relevance to sensory modulation are discussed below.

Membrane voltage

A significant number of TRP channels, mostly involved in sensory perception, have intrinsic voltage dependence [57-60]. The voltage-dependent activation of TRPs is sensitive to other triggers, such as the presence of ligands or changes in temperature that can alter the midpoint of the activation by several hundreds of millivolts [59,61]. Similar to voltage-gated potassium channels, the molecular counterparts involved in voltage sensing are probably positively charged lysine and arginine residues in transmembrane segment S4 and the S4-S5 linker [61]. For a recent review on voltage sensing and its relevance to the gating of TRP channels in response to thermal and chemical stimuli, see [62].

Membrane phospholipids

Several studies report a direct effect of membrane phospholipids in the regulation of TRP channel activity (for example, of TRPA1 and TRPV1) [63-65]. In particular, many TRPs are highly sensitive to phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P2), the most abundant acidic phospholipid in the plasma membrane. The plasma membrane level of PtdIns(4,5)P2 can change rapidly because of the action of different PLC isoforms and phosphatidylinositol kinases/phosphatases, resulting in modulation of TRP channel activity [66-68]. Many membrane-associated enzymes are also sensitive to changes in membrane PtdIns(4,5)P2 levels and, therefore, directly or indirectly can affect TRP channel function. For example, the membrane protein Pirt, which is required for the stimulatory effect of PtdIns(4,5)P2 on TRPV1 activity, interacts with both phosphoinositides and TRPV1 [64]. Cell-specific variations in the level of such regulatory proteins might explain at least some of the discrepancies relating to the effects of PtdIns(4,5)P2 on the TRP channel activity [29].

Another PtdIns(4,5)P2-related mechanism has been proposed for the cold- and menthol-sensitive TRPM8 and the Ca2+-activated taste-transducing TRPM5 channels. An increased intracellular Ca2+ concentration leads to activation of Ca2+-dependent PLC (such as PLCδ1), resulting in depletion of cellular PtdIns(4,5)P2 and a subsequent channel decay [69,70]. This PtdIns(4,5)P2 depletion does not lead to complete channel inactivation, but rather shifts the voltage dependence of channel activity to more positive potentials and reduces the channel sensitivity (desensitization) to ligands such as menthol (TRPM8) or Ca2+ (TRPM5) [71]. Endolysosome-localized TRPML channels interact directly with phosphatidylinositol 3,5-bisphosphate, an endolysosome-specific phosphoinositide, resulting in highly specific and potent activation of these channels [72].

Phosphorylation

Activation of PLC not only results in breakdown of PtdIns(4,5)P2 but also in the activation of protein kinase C (PKC). PKC-dependent phosphorylation might be a direct activatory mechanism or might sensitize the channel for other stimuli (for example, it sensitizes TRPV1 to heat or capsaicin) [73,74]. However, PKC might downregulate the channel function: activation of PKC initiates the dephosphorylation of TRPM8 and subsequent inactivation of this channel [75]. The identities of the kinases that mediate phosphorylation of TRPM8 and the phosphorylation site in TRPM8 are still unknown.

An additional pathway for the regulation of TRP channel activity following receptor stimulation is through protein kinase A (PKA). Activation of PKA by prostaglandin E2 stimulation potentiates TRPV1 responses and counteracts channel desensitization [74]. The PKA-dependent modulation of TRPV1 requires anchoring of PKA to the channel through the A-kinase anchoring protein AKAP150 and phosphorylation of a single amino-terminal serine residue [74,76]. In TRPM8, PKA activation leads to desensitization of the channel activity by an as yet unknown mechanism. Both PKA- and PKC-dependent pathways have opposite effects on modulation of the heat-activated TRPV1 and the cold-activated TRPM8 [77].

Ligands

Most TRP channel activities are modulated by a large number of exogenous and endogenous ligands. In particular, temperature-sensitive TRPs seem to be preferred targets for plant-derived chemicals. The classic example is heat-sensitive TRPV1, which is activated by structurally unrelated botanical compounds such as capsaicin (the pungent extract of hot peppers [78]), resiniferatoxin (an active compound from the cactus Euphorbia resinifera [79]), piperine (the pungent component in black pepper [80]) and camphor (the waxy substance with penetrating odor extracted from Cinnamomum camphora [81], which also activates TRPV3 [82]). Other examples include TRPM8, a cold receptor directly activated by menthol (derived from the mint plant Mentha piperita) and eucalyptol (derived from the tree Eucalyptus globulus), [83,84], and TRPV4, which is activated by bisandrographolide (derived from the plant Andrographis paniculata [85]). Thus, inherent thermal sensation linked to application of certain chemical compounds (chemesthesis) is related to activation of a single channel that can respond to both thermal and chemical stimuli (such as 'hot' chili pepper or 'cool' mint).

In addition to natural plant-derived compounds, TRP channels respond to a wide range of synthetic ligands, many of which are important pharmacological tools that can be used to modulate channel functions. Some can activate more than one TRP channel (for example, 2-aminoethyl diphenylborinate activates TRPV1, TRPV2 and TRPV3 [86,87] and icilin activates TRPM8 and TRPA1 [83,88]), whereas some are relatively highly selective for a particular TRP channel (such as olvanil for TRPV1 [89] and 4α-phorbol-12,13-didecanoate (4α-PDD), lumiphorbols, phorbol-hexonates and GSK 1016790A for TRPV4 [90-92]).

Several TRP channels are receptors for endogenous compounds. TRPCs respond to diacyl glycerol, a lipid product derived from PtdIns(4,5)P2 breakdown catalyzed by PLC after a G-protein- or tyrosine-kinase-coupled receptor-dependent activation [93]. Arachidonic-acid-related compounds are involved in gating TRPV1 (arachidonoyl ethanolamide, 12,15-(S)-hydroperoxyeicosatetraenoic acid and leukotriene B4 [94]) and TRPV4 (5',6'-epoxieicosatrienoic acid [95]), and sphingosine, a primary part of sphingolipids, activates TRPM3 [96]. However, the mechanisms of these gating behaviors of TRP channels are currently unknown.

Frontiers

The discovery of TRP channels has revolutionized our understanding of many sensory and general physiological processes. TRPs generally act in concert with other ion channels and proteins. Given that, in many cases, these mechanisms are evolutionarily conserved from invertebrates to humans, it is not surprising that inherited impairments of TRP channel functions lead to disease. In addition, changes in channel expression levels or channel sensitization or desensitization, resulting in exaggerated or diminished responses to various pathological stimuli, can also contribute to pathophysiology of TRP-related diseases. Various endogenous agents released during early disease stages can also influence TRP channel functions and lead to inflammation and the progression of the disease (for example, release of leukotriene B4 leads to TRPV1 activation). These findings highlight TRP channels as important pharmacological targets. Several TRPV1 antagonists function as analgesic agents for the treatment of chronic pathological pain [97]. The classic natural pungent TRPV1 agonist, capsaicin, has been reported as a possible relief agent for some patients with tonic neuropathic pain [98]. Several lines of evidence suggest that blocking TRPC6 function might be clinically beneficial for FSGS patients [99]. Preliminary results demonstrate that the commonly used immunosuppressive agent FK-506 can inhibit TRPC6 activity in vivo and might be a possible treatment for idiopathic FSGS [100]. Another example is a small molecule antagonist of TRPV4, HC-067047, which may provide promising means for the treatment of bladder dysfunction [101]. Therefore, further understanding of the (patho)physiological roles and activation mechanisms of these channels may provide novel insights into the etiology and possible treatments of many TRP-related diseases.

Acknowledgements

We thank all members of our laboratory for helpful comments and discussions. This work was supported by grants from Interuniversity Attraction Poles Programme (Belgian State - Belgian Science Policy, P6/28), the Research Foundation-Flanders (G.0172.03 and G.0565.07), the Research Council of the KU Leuven (GOA 2004/07) and the Flemish Government (Excellentiefinanciering, EF/95/010).

References

1. Cosens DJ, Manning A. Abnormal electroretinogram from a Drosophila mutant. Nature. 1969;224:285–287. doi: 10.1038/224285a0. [DOI] [PubMed] [Google Scholar]
2. Montell C, Rubin GM. Molecular characterization of the Drosophila trp locus: a putative integral membrane protein required for phototransduction. Neuron. 1989;2:1313–1323. doi: 10.1016/0896-6273(89)90069-X. [DOI] [PubMed] [Google Scholar]
3. Hardie RC, Minke B. The trp gene is essential for a light-activated Ca2+ channel in Drosophila photoreceptors. Neuron. 1992;8:643–651. doi: 10.1016/0896-6273(92)90086-S. [DOI] [PubMed] [Google Scholar]
4. Wu LJ, Sweet TB, Clapham DE. International Union of Basic and Clinical Pharmacology. LXXVI. Current progress in the mammalian TRP ion channel family. Pharmacol Rev. 2010;62:381–404. doi: 10.1124/pr.110.002725. [DOI] [PMC free article] [PubMed] [Google Scholar]
5. Sidi S, Friedrich RW, Nicolson T. NompC TRP channel required for vertebrate sensory hair cell mechanotransduction. Science. 2003;301:96–99. doi: 10.1126/science.1084370. [DOI] [PubMed] [Google Scholar]
6. Cavalier-Smith T. Only six kingdoms of life. Proc Biol Sci. 2004;271:1251–1262. doi: 10.1098/rspb.2004.2705. [DOI] [PMC free article] [PubMed] [Google Scholar]
7. Wheeler GL, Brownlee C. Ca(2+) signalling in plants and green algae - changing channels. Trends Plant Sci. 2008;13:506–514. doi: 10.1016/j.tplants.2008.06.004. [DOI] [PubMed] [Google Scholar]
8. Zhou X, Su Z, Anishkin A, Haynes WJ, Friske EM, Loukin SH, Kung C, Saimi Y. Yeast screens show aromatic residues at the end of the sixth helix anchor transient receptor potential channel gate. Proc Natl Acad Sci USA. 2007;104:15555–15559. doi: 10.1073/pnas.0704039104. [DOI] [PMC free article] [PubMed] [Google Scholar]
9. Su Z, Zhou X, Haynes WJ, Loukin SH, Anishkin A, Saimi Y, Kung C. Yeast gain-of-function mutations reveal structure-function relationships conserved among different subfamilies of transient receptor potential channels. Proc Natl Acad Sci USA. 2007;104:19607–19612. doi: 10.1073/pnas.0708584104. [DOI] [PMC free article] [PubMed] [Google Scholar]
10. Myers BR, Bohlen CJ, Julius D. A yeast genetic screen reveals a critical role for the pore helix domain in TRP channel gating. Neuron. 2008;58:362–373. doi: 10.1016/j.neuron.2008.04.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
11. Chang Y, Schlenstedt G, Flockerzi V, Beck A. Properties of the intracellular transient receptor potential (TRP) channel in yeast, Yvc1. FEBS Lett. 2010;584:2028–2032. doi: 10.1016/j.febslet.2009.12.035. [DOI] [PubMed] [Google Scholar]
12. Su Z, Zhou X, Loukin SH, Haynes WJ, Saimi Y, Kung C. The use of yeast to understand TRP-channel mechanosensitivity. Pflugers Arch. 2009;458:861–867. doi: 10.1007/s00424-009-0680-0. [DOI] [PubMed] [Google Scholar]
13. Su Z, Zhou X, Loukin SH, Saimi Y, Kung C. Mechanical force and cytoplasmic Ca(2+) activate yeast TRPY1 in parallel. J Membr Biol. 2009;227:141–150. doi: 10.1007/s00232-009-9153-9. [DOI] [PubMed] [Google Scholar]
14. Palmer CP, Zhou XL, Lin J, Loukin SH, Kung C, Saimi Y. A TRP homolog in Saccharomyces cerevisiae forms an intracellular Ca2+- permeable channel in the yeast vacuolar membrane. Proc Natl Acad Sci USA. 2001;98:7801–7805. doi: 10.1073/pnas.141036198. [DOI] [PMC free article] [PubMed] [Google Scholar]
15. Denis V, Cyert MS. Internal Ca2+ release in yeast is triggered by hypertonic shock and mediated by a TRP channel homologue. J Cell Biol. 2002;156:29–34. doi: 10.1083/jcb.200111004. [DOI] [PMC free article] [PubMed] [Google Scholar]
16. Cai X. Unicellular Ca2+ signaling 'toolkit' at the origin of metazoa. Mol Biol Evol. 2008;25:1357–1361. doi: 10.1093/molbev/msn077. [DOI] [PubMed] [Google Scholar]
17. Hofmann T, Schaefer M, Schultz G, Gudermann T. Subunit composition of mammalian transient receptor potential channels in living cells. Proc Natl Acad Sci USA. 2002;99:7461–7466. doi: 10.1073/pnas.102596199. [DOI] [PMC free article] [PubMed] [Google Scholar]
18. Owsianik G, D'Hoedt D, Voets T, Nilius B. Structure-function relationship of the TRP channel superfamily. Rev Physiol Biochem Pharmacol. 2006;156:61–90. full_text. [PubMed] [Google Scholar]
19. Gaudet R. TRP channels entering the structural era. J Physiol. 2008;586:3565–3575. doi: 10.1113/jphysiol.2008.155812. [DOI] [PMC free article] [PubMed] [Google Scholar]
20. Mio K, Ogura T, Kiyonaka S, Hiroaki Y, Tanimura Y, Fujiyoshi Y, Mori Y, Sato C. The TRPC3 channel has a large internal chamber surrounded by signal sensing antennas. J Mol Biol. 2007;367:373–383. doi: 10.1016/j.jmb.2006.12.043. [DOI] [PubMed] [Google Scholar]
21. Perraud AL, Fleig A, Dunn CA, Bagley LA, Launay P, Schmitz C, Stokes AJ, Zhu Q, Bessman MJ, Penner R, Kinet JP, Scharenberg AM. ADP-ribose gating of the calcium-permeable LTRPC2 channel revealed by Nudix motif homology. Nature. 2001;411:595–599. doi: 10.1038/35079100. [DOI] [PubMed] [Google Scholar]
22. Runnels LW, Yue L, Clapham DE. TRP-PLIK, a bifunctional protein with kinase and ion channel activities. Science. 2001;291:1043–1047. doi: 10.1126/science.1058519. [DOI] [PubMed] [Google Scholar]
23. Nadler MJ, Hermosura MC, Inabe K, Perraud AL, Zhu Q, Stokes AJ, Kurosaki T, Kinet JP, Penner R, Scharenberg AM, Fleig A. LTRPC7 is a Mg.ATP-regulated divalent cation channel required for cell viability. Nature. 2001;411:590–595. doi: 10.1038/35079092. [DOI] [PubMed] [Google Scholar]
24. Gaudet R. A primer on ankyrin repeat function in TRP channels and beyond. Mol Biosyst. 2008;4:372–379. doi: 10.1039/b801481g. [DOI] [PMC free article] [PubMed] [Google Scholar]
25. Jin X, Touhey J, Gaudet R. Structure of the N-terminal ankyrin repeat domain of the TRPV2 ion channel. J Biol Chem. 2006;281:25006–25010. doi: 10.1074/jbc.C600153200. [DOI] [PubMed] [Google Scholar]
26. Gaudet R. Divide and conquer: high resolution structural information on TRP channel fragments. J Gen Physiol. 2009;133:231–237. doi: 10.1085/jgp.200810137. [DOI] [PMC free article] [PubMed] [Google Scholar]
27. Cuajungco MP, Grimm C, Oshima K, D'Hoedt D, Nilius B, Mensenkamp AR, Bindels RJ, Plomann M, Heller S. PACSINs bind to the TRPV4 cation channel. PACSIN 3 modulates the subcellular localization of TRPV4. J Biol Chem. 2006;281:18753–18762. doi: 10.1074/jbc.M602452200. [DOI] [PubMed] [Google Scholar]
28. D'Hoedt D, Owsianik G, Prenen J, Cuajungco MP, Grimm C, Heller S, Voets T, Nilius B. Stimulus-specific modulation of the cation channel TRPV4 by PACSIN 3. J Biol Chem. 2008;283:6272–6280. doi: 10.1074/jbc.M706386200. [DOI] [PubMed] [Google Scholar]
29. Gees M, Colsoul B, Nilius B. The role of transient receptor potential cation channels in Ca2+ signaling. Cold Spring Harb Perspect Biol. 2010;2:a003962. doi: 10.1101/cshperspect.a003962. [DOI] [PMC free article] [PubMed] [Google Scholar]
30. Nilius B, Owsianik G, Voets T, Peters JA. Transient receptor potential cation channels in disease. Physiol Rev. 2007;87:165–217. doi: 10.1152/physrev.00021.2006. [DOI] [PubMed] [Google Scholar]
31. Nilius B, Owsianik G. Transient receptor potential channelopathies. Pflugers Arch. 2010;460:437–450. doi: 10.1007/s00424-010-0788-2. [DOI] [PubMed] [Google Scholar]
32. Kriz W. TRPC6 - a new podocyte gene involved in focal segmental glomerulosclerosis. Trends Mol Med. 2005;11:527–530. doi: 10.1016/j.molmed.2005.10.001. [DOI] [PubMed] [Google Scholar]
33. Reiser J, Polu KR, Moller CC, Kenlan P, Altintas MM, Wei C, Faul C, Herbert S, Villegas I, Avila-Casado C, McGee M, Sugimoto H, Brown D, Kalluri R, Mundel P, Smith PL, Clapham DE, Pollak MR. TRPC6 is a glomerular slit diaphragm-associated channel required for normal renal function. Nat Genet. 2005;37:739–744. doi: 10.1038/ng1592. [DOI] [PMC free article] [PubMed] [Google Scholar]
34. Winn MP, Conlon PJ, Lynn KL, Farrington MK, Creazzo T, Hawkins AF, Daskalakis N, Kwan SY, Eversviller S, Burchette JL, Pericak-Vance MA, Howell DN, Vance JM, Rosenberg PB. A mutation in the TRPC6 Cation channel causes familial focal segmental glomerulosclerosis. Science. 2005;308:1801–1804. doi: 10.1126/science.1106215. [DOI] [PubMed] [Google Scholar]
35. Rock MJ, Prenen J, Funari VA, Funari TL, Merriman B, Nelson SF, Lachman RS, Wilcox WR, Reyno S, Quadrelli R, Vaglio A, Owsianik G, Janssens A, Voets T, Ikegawa S, Nagai T, Rimoin DL, Nilius B, Cohn DH. Gain-of-function mutations in TRPV4 cause autosomal dominant brachyolmia. Nat Genet. 2008;40:999–1003. doi: 10.1038/ng.166. [DOI] [PMC free article] [PubMed] [Google Scholar]
36. Deng HX, Klein CJ, Yan J, Shi Y, Wu Y, Fecto F, Yau HJ, Yang Y, Zhai H, Siddique N, Hedley-Whyte ET, Delong R, Martina M, Dyck PJ, Siddique T. Scapuloperoneal spinal muscular atrophy and CMT2C are allelic disorders caused by alterations in TRPV4. Nat Genet. 2010;42:165–169. doi: 10.1038/ng.509. [DOI] [PMC free article] [PubMed] [Google Scholar]
37. Landoure G, Zdebik AA, Martinez TL, Burnett BG, Stanescu HC, Inada H, Shi Y, Taye AA, Kong L, Munns CH, Choo SS, Phelps CB, Paudel R, Houlden H, Ludlow CL, Caterina MJ, Gaudet R, Kleta R, Fischbeck KH, Sumner CJ. Mutations in TRPV4 cause Charcot-Marie-Tooth disease type 2C. Nat Genet. 2010;42:170–174. doi: 10.1038/ng.512. [DOI] [PMC free article] [PubMed] [Google Scholar]
38. Nilius B, Owsianik G. Channelopathies converge on TRPV4. Nat Genet. 2010;42:98–100. doi: 10.1038/ng0210-98. [DOI] [PubMed] [Google Scholar]
39. Auer-Grumbach M, Olschewski A, Papic L, Kremer H, McEntagart ME, Uhrig S, Fischer C, Frohlich E, Balint Z, Tang B, Strohmaier H, Lochmüller H, Schlotter-Weigel B, Senderek J, Krebs A, Dick KJ, Petty R, Longman C, Anderson NE, Padberg GW, Schelhaas HJ, van Ravenswaaij-Arts CM, Pieber TR, Crosby AH, Guelly C. Alterations in the ankyrin domain of TRPV4 cause congenital distal SMA, scapuloperoneal SMA and HMSN2C. Nat Genet. 2010;42:160–164. doi: 10.1038/ng.508. [DOI] [PMC free article] [PubMed] [Google Scholar]
40. Miller AJ, Du J, Rowan S, Hershey CL, Widlund HR, Fisher DE. Transcriptional regulation of the melanoma prognostic marker melastatin (TRPM1) by MITF in melanocytes and melanoma. Cancer Res. 2004;64:509–516. doi: 10.1158/0008-5472.CAN-03-2440. [DOI] [PubMed] [Google Scholar]
41. Duncan LM, Deeds J, Cronin FE, Donovan M, Sober AJ, Kauffman M, McCarthy JJ. Melastatin expression and prognosis in cutaneous malignant melanoma. J Clin Oncol. 2001;19:568–576. doi: 10.1200/JCO.2001.19.2.568. [DOI] [PubMed] [Google Scholar]
42. Duncan LM, Deeds J, Hunter J, Shao J, Holmgren LM, Woolf EA, Tepper RI, Shyjan AW. Down-regulation of the novel gene melastatin correlates with potential for melanoma metastasis. Cancer Res. 1998;58:1515–1520. [PubMed] [Google Scholar]
43. Audo I, Kohl S, Leroy BP, Munier FL, Guillonneau X, Mohand-Said S, Bujakowska K, Nandrot EF, Lorenz B, Preising M, Kellner U, Renner AB, Bernd A, Antonio A, Moskova-Doumanova V, Lancelot ME, Poloschek CM, Drumare I, Defoort-Dhellemmes S, Wissinger B, Léveillard T, Hamel CP, Schorderet DF, De Baere E, Berger W, Jacobson SG, Zrenner E, Sahel JA, Bhattacharya SS, Zeitz C. TRPM1 is mutated in patients with autosomal-recessive complete congenital stationary night blindness. Am J Hum Genet. 2009;85:720–729. doi: 10.1016/j.ajhg.2009.10.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
44. Bellone RR, Brooks SA, Sandmeyer L, Murphy BA, Forsyth G, Archer S, Bailey E, Grahn B. Differential gene expression of TRPM1, the potential cause of congenital stationary night blindness and coat spotting patterns (LP) in the Appaloosa horse (Equus caballus). Genetics. 2008;179:1861–1870. doi: 10.1534/genetics.108.088807. [DOI] [PMC free article] [PubMed] [Google Scholar]
45. Nakajima Y, Moriyama M, Hattori M, Minato N, Nakanishi S. Isolation of ON bipolar cell genes via hrGFP-coupled cell enrichment using the mGluR6 promoter. J Biochem. 2009;145:811–818. doi: 10.1093/jb/mvp038. [DOI] [PubMed] [Google Scholar]
46. van Genderen MM, Bijveld MM, Claassen YB, Florijn RJ, Pearring JN, Meire FM, McCall MA, Riemslag FC, Gregg RG, Bergen AA, Kamermans M. Mutations in TRPM1 are a common cause of complete congenital stationary night blindness. Am J Hum Genet. 2009;85:730–736. doi: 10.1016/j.ajhg.2009.10.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
47. Li Z, Sergouniotis PI, Michaelides M, Mackay DS, Wright GA, Devery S, Moore AT, Holder GE, Robson AG, Webster AR. Recessive mutations of the gene TRPM1 abrogate ON bipolar cell function and cause complete congenital stationary night blindness in humans. Am J Hum Genet. 2009;85:711–719. doi: 10.1016/j.ajhg.2009.10.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
48. Kruse M, Schulze-Bahr E, Corfield V, Beckmann A, Stallmeyer B, Kurtbay G, Ohmert I, Brink P, Pongs O. Impaired endocytosis of the ion channel TRPM4 is associated with human progressive familial heart block type I. J Clin Invest. 2009;119:2737–2744. doi: 10.1172/JCI38292. [DOI] [PMC free article] [PubMed] [Google Scholar]
49. Schlingmann KP, Sassen MC, Weber S, Pechmann U, Kusch K, Pelken L, Lotan D, Syrrou M, Prebble JJ, Cole DE, Metzger DL, Rahman S, Tajima T, Shu SG, Waldegger S, Seyberth HW, Konrad M. Novel TRPM6 mutations in 21 families with primary hypomagnesemia and secondary hypocalcemia. J Am Soc Nephrol. 2005;16:3061–3069. doi: 10.1681/ASN.2004110989. [DOI] [PubMed] [Google Scholar]
50. Walder RY, Landau D, Meyer P, Shalev H, Tsolia M, Borochowitz Z, Boettger MB, Beck GE, Englehardt RK, Carmi R, Sheffield VC. Mutation of TRPM6 causes familial hypomagnesemia with secondary hypocalcemia. Nat Genet. 2002;31:171–174. doi: 10.1038/ng901. [DOI] [PubMed] [Google Scholar]
51. Voets T, Nilius B, Hoefs S, van der Kemp AW, Droogmans G, Bindels RJ, Hoenderop JG. TRPM6 forms the Mg2+ influx channel involved in intestinal and renal Mg2+ absorption. J Biol Chem. 2004;279:19–25. doi: 10.1074/jbc.M311201200. [DOI] [PubMed] [Google Scholar]
52. Kremeyer B, Lopera F, Cox JJ, Momin A, Rugiero F, Marsh S, Woods CG, Jones NG, Paterson KJ, Fricker FR, Villegas A, Acosta N, Pineda-Trujillo NG, Ramírez JD, Zea J, Burley MW, Bedoya G, Bennett DL, Wood JN, Ruiz-Linares A. A gain-of-function mutation in TRPA1 causes familial episodic pain syndrome. Neuron. 2010;66:671–680. doi: 10.1016/j.neuron.2010.04.030. [DOI] [PMC free article] [PubMed] [Google Scholar]
53. Bach G. Mucolipin 1: endocytosis and cation channel-a review. Pflugers Arch. 2005;451:313–317. doi: 10.1007/s00424-004-1361-7. [DOI] [PubMed] [Google Scholar]
54. Cheng X, Shen D, Samie M, Xu H. Mucolipins: intracellular TRPML1-3 channels. FEBS Lett. 2010;584:2013–2021. doi: 10.1016/j.febslet.2009.12.056. [DOI] [PMC free article] [PubMed] [Google Scholar]
55. Puertollano R, Kiselyov K. TRPMLs: in sickness and in health. Am J Physiol Renal Physiol. 2009;296:F1245–1254. doi: 10.1152/ajprenal.90522.2008. [DOI] [PMC free article] [PubMed] [Google Scholar]
56. Grantham JJ. Polycystic kidney disease: hereditary and acquired. Adv Intern Med. 1993;38:409–420. [PubMed] [Google Scholar]
57. Nilius B, Prenen J, Droogmans G, Voets T, Vennekens R, Freichel M, Wissenbach U, Flockerzi V. Voltage dependence of the Ca2+-activated cation channel TRPM4. J Biol Chem. 2003;278:30813–30820. doi: 10.1074/jbc.M305127200. [DOI] [PubMed] [Google Scholar]
58. Nilius B, Talavera K, Owsianik G, Prenen J, Droogmans G, Voets T. Gating of TRP channels: a voltage connection? J Physiol (Lond) 2005;567:33–44. doi: 10.1113/jphysiol.2005.093245. [DOI] [PMC free article] [PubMed] [Google Scholar]
59. Voets T, Droogmans G, Wissenbach U, Janssens A, Flockerzi V, Nilius B. The principle of temperature-dependent gating in cold- and heat-sensitive TRP channels. Nature. 2004;430:748–754. doi: 10.1038/nature02732. [DOI] [PubMed] [Google Scholar]
60. Voets T, Talavera K, Owsianik G, Nilius B. Sensing with TRP channels. Nat Biol Chem. 2005;1:85–92. doi: 10.1038/nchembio0705-85. [DOI] [PubMed] [Google Scholar]
61. Voets T, Owsianik G, Janssens A, Talavera K, Nilius B. TRPM8 voltage sensor mutants reveal a mechanism for integrating thermal and chemical stimuli. Nat Chem Biol. 2007;3:174–182. doi: 10.1038/nchembio862. [DOI] [PubMed] [Google Scholar]
62. Talavera K, Yasumatsu K, Yoshida R, Margolskee RF, Voets T, Ninomiya Y, Nilius B. The taste transduction channel TRPM5 is a locus for bitter-sweet taste interactions. FASEB J. 2008;22:1343–1355. doi: 10.1096/fj.07-9591com. [DOI] [PubMed] [Google Scholar]
63. Karashima Y, Prenen J, Meseguer V, Owsianik G, Voets T, Nilius B. Modulation of the transient receptor potential channel TRPA1 by phosphatidylinositol 4,5-biphosphate manipulators. Pflugers Arch. 2008;457:77–89. doi: 10.1007/s00424-008-0493-6. [DOI] [PubMed] [Google Scholar]
64. Kim AY, Tang Z, Liu Q, Patel KN, Maag D, Geng Y, Dong X. Pirt, a phosphoinositide-binding protein, functions as a regulatory subunit of TRPV1. Cell. 2008;133:475–485. doi: 10.1016/j.cell.2008.02.053. [DOI] [PMC free article] [PubMed] [Google Scholar]
65. Stein AT, Ufret-Vincenty CA, Hua L, Santana LF, Gordon SE. Phosphoinositide 3-kinase binds to TRPV1 and mediates NGF-stimulated TRPV1 trafficking to the plasma membrane. J Gen Physiol. 2006;128:509–522. doi: 10.1085/jgp.200609576. [DOI] [PMC free article] [PubMed] [Google Scholar]
66. Nilius B, Owsianik G, Voets T. Transient receptor potential channels meet phosphoinositides. EMBO J. 2008;27:2809–2816. doi: 10.1038/emboj.2008.217. [DOI] [PMC free article] [PubMed] [Google Scholar]
67. Rohacs T, Nilius B. Regulation of transient receptor potential (trp) channels by phosphoinositides. Pflugers Arch. 2007;455:157–168. doi: 10.1007/s00424-007-0275-6. [DOI] [PubMed] [Google Scholar]
68. Voets T, Nilius B. Modulation of TRPs by PIPs. J Physiol. 2007;582:939–944. doi: 10.1113/jphysiol.2007.132522. [DOI] [PMC free article] [PubMed] [Google Scholar]
69. Liu B, Qin F. Functional control of cold- and menthol-sensitive TRPM8 ion channels by phosphatidylinositol 4,5-bisphosphate. J Neurosci. 2005;25:1674–1681. doi: 10.1523/JNEUROSCI.3632-04.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
70. Rohacs T, Lopes CM, Michailidis I, Logothetis DE. PI(4,5)P(2) regulates the activation and desensitization of TRPM8 channels through the TRP domain. Nat Neurosci. 2005;8:626–634. doi: 10.1038/nn1451. [DOI] [PubMed] [Google Scholar]
71. Nilius B, Mahieu F, Prenen J, Janssens A, Owsianik G, Vennekens R, Voets T. The Ca2+-activated cation channel TRPM4 is regulated by phosphatidylinositol 4,5-biphosphate. EMBO J. 2006;25:467–478. doi: 10.1038/sj.emboj.7600963. [DOI] [PMC free article] [PubMed] [Google Scholar]
72. Dong XP, Shen D, Wang X, Dawson T, Li X, Zhang Q, Cheng X, Zhang Y, Weisman LS, Delling M, Xu H. PI(3,5)P(2) controls membrane traffic by direct activation of mucolipin Ca release channels in the endolysosome. Nat Commun. 2010;1:pii38. doi: 10.1038/ncomms1037. [DOI] [PMC free article] [PubMed] [Google Scholar]
73. Premkumar LS, Ahern GP. Induction of vanilloid receptor channel activity by protein kinase C. Nature. 2000;408:985–990. doi: 10.1038/35050121. [DOI] [PubMed] [Google Scholar]
74. Bhave G, Hu HJ, Glauner KS, Zhu W, Wang H, Brasier DJ, Oxford GS, Gereau RWt. Protein kinase C phosphorylation sensitizes but does not activate the capsaicin receptor transient receptor potential vanilloid 1 (TRPV1). Proc Natl Acad Sci USA. 2003;100:12480–12485. doi: 10.1073/pnas.2032100100. [DOI] [PMC free article] [PubMed] [Google Scholar]
75. Premkumar LS, Raisinghani M, Pingle SC, Long C, Pimentel F. Downregulation of transient receptor potential melastatin 8 by protein kinase C-mediated dephosphorylation. J Neurosci. 2005;25:11322–11329. doi: 10.1523/JNEUROSCI.3006-05.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
76. Jeske NA, Diogenes A, Ruparel NB, Fehrenbacher JC, Henry M, Akopian AN, Hargreaves KM. A-kinase anchoring protein mediates TRPV1 thermal hyperalgesia through PKA phosphorylation of TRPV1. Pain. 2008;38:604–616. doi: 10.1016/j.pain.2008.02.022. [DOI] [PMC free article] [PubMed] [Google Scholar]
77. De Petrocellis L, Starowicz K, Moriello AS, Vivese M, Orlando P, Di Marzo V. Regulation of transient receptor potential channel of melastatin type 8 (TRPM8): effect of CAMP, cannabinoid and endovailloids. Exp Cell Res. 2007;313:1911–1920. doi: 10.1016/j.yexcr.2007.01.008. [DOI] [PubMed] [Google Scholar]
78. Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, Julius D. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature. 1997;389:816–824. doi: 10.1038/39807. [DOI] [PubMed] [Google Scholar]
79. Szallasi A, Szabo T, Biro T, Modarres S, Blumberg PM, Krause JE, Cortright DN, Appendino G. Resiniferatoxin-type phorboid vanilloids display capsaicin-like selectivity at native vanilloid receptors on rat DRG neurons and at the cloned vanilloid receptor VR1. Br J Pharmacol. 1999;128:428–434. doi: 10.1038/sj.bjp.0702810. [DOI] [PMC free article] [PubMed] [Google Scholar]
80. McNamara FN, Randall A, Gunthorpe MJ. Effects of piperine, the pungent component of black pepper, at the human vanilloid receptor (TRPV1). Br J Pharmacol. 2005;144:781–790. doi: 10.1038/sj.bjp.0706040. [DOI] [PMC free article] [PubMed] [Google Scholar]
81. Xu H, Blair NT, Clapham DE. Camphor activates and strongly desensitizes the transient receptor potential vanilloid subtype 1 channel in a vanilloid-independent mechanism. J Neurosci. 2005;25:8924–8937. doi: 10.1523/JNEUROSCI.2574-05.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
82. Moqrich A, Hwang SW, Earley TJ, Petrus MJ, Murray AN, Spencer KS, Andahazy M, Story GM, Patapoutian A. Impaired thermosensation in mice lacking TRPV3, a heat and camphor sensor in the skin. Science. 2005;307:1468–1472. doi: 10.1126/science.1108609. [DOI] [PubMed] [Google Scholar]
83. McKemy DD, Neuhausser WM, Julius D. Identification of a cold receptor reveals a general role for TRP channels in thermosensation. Nature. 2002;416:52–58. doi: 10.1038/nature719. [DOI] [PubMed] [Google Scholar]
84. Peier AM, Moqrich A, Hergarden AC, Reeve AJ, Andersson DA, Story GM, Earley TJ, Dragoni I, McIntyre P, Bevan S, Patapoutian A. A TRP channel that senses cold stimuli and menthol. Cell. 2002;108:705–715. doi: 10.1016/S0092-8674(02)00652-9. [DOI] [PubMed] [Google Scholar]
85. Smith PL, Maloney KN, Pothen RG, Clardy J, Clapham DE. Bisandrographolide from Andrographis paniculata activates TRPV4 channels. J Biol Chem. 2006;281:29897–29904. doi: 10.1074/jbc.M605394200. [DOI] [PubMed] [Google Scholar]
86. Chung MK, Lee H, Mizuno A, Suzuki M, Caterina MJ. 2-aminoethoxydiphenyl borate activates and sensitizes the heat-gated ion channel TRPV3. J Neurosci. 2004;24:5177–5182. doi: 10.1523/JNEUROSCI.0934-04.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
87. Hu HZ, Gu Q, Wang C, Colton CK, Tang J, Kinoshita-Kawada M, Lee LY, Wood JD, Zhu MX. 2-aminoethoxydiphenyl borate is a common activator of TRPV1, TRPV2, and TRPV3. J Biol Chem. 2004;279:35741–35748. doi: 10.1074/jbc.M404164200. [DOI] [PubMed] [Google Scholar]
88. Story GM, Peier AM, Reeve AJ, Eid SR, Mosbacher J, Hricik TR, Earley TJ, Hergarden AC, Andersson DA, Hwang SW, McIntyre P, Jegla T, Bevan S, Patapoutian A. ANKTM1, a TRP-like channel expressed in nociceptive neurons, is activated by cold temperatures. Cell. 2003;112:819–829. doi: 10.1016/S0092-8674(03)00158-2. [DOI] [PubMed] [Google Scholar]
89. Iida T, Moriyama T, Kobata K, Morita A, Murayama N, Hashizume S, Fushiki T, Yazawa S, Watanabe T, Tominaga M. TRPV1 activation and induction of nociceptive response by a non-pungent capsaicin-like compound, capsiate. Neuropharmacology. 2003;44:958–967. doi: 10.1016/S0028-3908(03)00100-X. [DOI] [PubMed] [Google Scholar]
90. Watanabe H, Davis JB, Smart D, Jerman JC, Smith GD, Hayes P, Vriens J, Cairns W, Wissenbach U, Prenen J, Flockerzi V, Droogmans G, Benham CD, Nilius B. Activation of TRPV4 channels (hVRL-2/mTRP12) by phorbol derivatives. J Biol Chem. 2002;277:13569–13577. doi: 10.1074/jbc.M200062200. [DOI] [PubMed] [Google Scholar]
91. Klausen TK, Pagani A, Minassi A, Ech-Chahad A, Prenen J, Owsianik G, Hoffmann EK, Pedersen SF, Appendino G, Nilius B. Modulation of the transient receptor potential vanilloid channel TRPV4 by 4alpha-phorbol esters: a structure-activity study. J Med Chem. 2009;52:2933–2939. doi: 10.1021/jm9001007. [DOI] [PubMed] [Google Scholar]
92. Thorneloe KS, Sulpizio AC, Lin Z, Figueroa DJ, Clouse AK, McCafferty GP, Chendrimada TP, Lashinger ES, Gordon E, Evans L, Misajet BA, Demarini DJ, Nation JH, Casillas LN, Marquis RW, Votta BJ, Sheardown SA, Xu X, Brooks DP, Laping NJ, Westfall TD. N-((1S)-1-{[4-((2S)-2-{[(2,4-dichlorophenyl)sulfonyl]amino}-3-hydroxypropa noyl)-1-piperazinyl]carbonyl}-3-methylbutyl)-1-benzothiophene-2-carboxamide (GSK1016790A), a novel and potent transient receptor potential vanilloid 4 channel agonist induces urinary bladder contraction and hyperactivity: Part I. J Pharmacol Exp Ther. 2008;326:432–442. doi: 10.1124/jpet.108.139295. [DOI] [PubMed] [Google Scholar]
93. Kiselyov K, Patterson RL. The integrative function of TRPC channels. Front Biosci. 2009;14:45–58. doi: 10.2741/3230. [DOI] [PubMed] [Google Scholar]
94. Zygmunt PM, Petersson J, Andersson DA, Chuang H, Sorgard M, Di Marzo V, Julius D, Hogestatt ED. Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature. 1999;400:452–457. doi: 10.1038/22761. [DOI] [PubMed] [Google Scholar]
95. Watanabe H, Vriens J, Prenen J, Droogmans G, Voets T, Nilius B. Anandamide and arachidonic acid use epoxyeicosatrienoic acids to activate TRPV4 channels. Nature. 2003;424:434–438. doi: 10.1038/nature01807. [DOI] [PubMed] [Google Scholar]
96. Grimm C, Kraft R, Schultz G, Harteneck C. Activation of the melastatin-related cation channel TRPM3 by D-erythro-sphingosine [corrected]. Mol Pharmacol. 2005;67:798–805. doi: 10.1124/mol.104.006734. [DOI] [PubMed] [Google Scholar]
97. Kym PR, Kort ME, Hutchins CW. Analgesic potential of TRPV1 antagonists. Biochem Pharmacol. 2009;78:211–216. doi: 10.1016/j.bcp.2009.02.014. [DOI] [PubMed] [Google Scholar]
98. Derry S, Lloyd R, Moore RA, McQuay HJ. Topical capsaicin for chronic neuropathic pain in adults. Cochrane Database Syst Rev. 2009. p. CD007393. [DOI] [PMC free article] [PubMed]
99. Mukerji N, Damodaran TV, Winn MP. TRPC6 and FSGS: the latest TRP channelopathy. Biochim Biophys Acta. 2007;1772:859–868. doi: 10.1016/j.bbadis.2007.03.005. [DOI] [PubMed] [Google Scholar]
100. Sinkins WG, Goel M, Estacion M, Schilling WP. Association of immunophilins with mammalian TRPC channels. J Biol Chem. 2004;279:34521–34529. doi: 10.1074/jbc.M401156200. [DOI] [PubMed] [Google Scholar]
101. Everaerts W, Zhen X, Ghosh D, Vriens J, Gevaert T, Gilbert JP, Hayward NJ, McNamara CR, Xue F, Moran MM, Strassmaier T, Uykal E, Owsianik G, Vennekens R, De Ridder D, Nilius B, Fanger CM, Voets T. Inhibition of the cation channel TRPV4 improves bladder function in mice and rats with cyclophosphamide-induced cystitis. Proc Natl Acad Sci USA. 2010;107:19084–19089. doi: 10.1073/pnas.1005333107. [DOI] [PMC free article] [PubMed] [Google Scholar]
102. Perriere G, Gouy M. WWW-query: an on-line retrieval system for biological sequence banks. Biochimie. 1996;78:364–369. doi: 10.1016/0300-9084(96)84768-7. [DOI] [PubMed] [Google Scholar]
103. Clapham DI, Nilius B, Owsianik G. Transient Receptor Potential Channels. IUPHAR database. http://www.iuphar-db.org/DATABASE/FamilyMenuForward?familyId=78
104. Montell C. TRP channels in Drosophila photoreceptor cells. J Physiol. 2005;567:45–51. doi: 10.1113/jphysiol.2005.092551. [DOI] [PMC free article] [PubMed] [Google Scholar]
105. Venkatachalam K, Montell C. TRP channels. Annu Rev Biochem. 2007;76:387–417. doi: 10.1146/annurev.biochem.75.103004.142819. [DOI] [PMC free article] [PubMed] [Google Scholar]
106. Christensen AP, Corey DP. TRP channels in mechanosensation: direct or indirect activation? Nat Rev Neurosci. 2007;8:510–521. doi: 10.1038/nrn2149. [DOI] [PubMed] [Google Scholar]